Allow home infusions for some Medicare patients with a rare genetic disease

Salazar introduced the John W. Walsh Alpha-1 Home Infusion Act, which would allow Medicare beneficiaries with alpha-1 antitrypsin deficiency to receive treatment at home. She says the change is intended to reduce healthcare costs and improve patients’ quality of life.

Context: The passage describes an introduced bill, not an enacted law.

In their own words

Introduced the John W. Walsh Alpha-1 Home Infusion Act.

The source

Maria Elvira Salazar: Healthcare ↗

Published: Original date not established; campaign context manually checked
Retrieved: 11/10/2026